Cashuistic case of treatment of discemned small-cell lung cancer


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Despite the increase in the incidence of neuroendocrine tumors (NET) in recent decades, the diagnosis of bronchopulmonary NET predominantly occurs in the disseminated form of the disease. The clinical course of small-cell lung cancer is characterized by rapid growth, early lymphogenous and haematogenic metastases, and high sensitivity to pharmacotherapy and radiation treatment, but the results of treatment remain unsatisfactory. This clinical case of successful treatment of disseminated small-cell lung cancer reflects the individuality of tumor sensitivity to combined treatment.

Texto integral

Acesso é fechado

Sobre autores

G. Khakimova

FSBI “Russian Oncological Research Center n.a. N.N. Blokhin" of RMH

Email: hgg_doc@mail.ru
Clinical Resident Doctor at the Department of Chemotherapy

T. Titova

FSBI “Russian Oncological Research Center n.a. N.N. Blokhin" of RMH

A. Kuzminov

FSBI “Russian Oncological Research Center n.a. N.N. Blokhin" of RMH

V. Gorbunova

FSBI “Russian Oncological Research Center n.a. N.N. Blokhin" of RMH

V. Delektorskaya

FSBI “Russian Oncological Research Center n.a. N.N. Blokhin" of RMH

T. Borisova

FSBI “Russian Oncological Research Center n.a. N.N. Blokhin" of RMH

Bibliografia

  1. Yao J.C., Hassan M., Phan A., Dagohoy C., Leary C., Mares J.E., Abdalla E.K., Fleming J.B., Vauthey J.N., Rashid A., Evans D.B. One hundred years after «carcinoid»: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United StatesJ. Clin. Oncol. 2008;26:3063-72.
  2. Govindan R., Page N., Morgensztern D., Read W., Tierney R., Vlahiotis A., Spitznagel E.L., Piccirillo J. Changing epidemiology of smallcell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J. Clin. Oncol. 2006;24:4539-44.
  3. Semenova E.A., Nagel R., Berns A. Origins, Genetic Landscape, and Emerging Therapies of Small Cell Lung Cancer. Review. Genes Dev. 2015;29(14):1447-62.
  4. Jett J.R., Schild S.E., Kesler K.A., Kalemkerian G.P. Treatment of small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e400S-19.
  5. Fruh M., De Ruysscher D., Popat S., Crinò L., Peters S., Felip E. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013;24:99-105.
  6. Slotman B., Faivre-Finn C., Kramer G., Rankin E., Snee M., Hatton M., Postmus P., Collette L., Musat E., Senan S. Prophylactic cranial irradiation in extensive small-cell lung cancer. N. Engl. J. Med. 2007;357:664-72.
  7. Jeremic B., Shibamoto Y., Nikolic N., Milicic B., Milisavljevic S., Dagovic A., Aleksandrovic J., Radosavljevic-Asic G. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J. Clin. Oncol. 1999; 17:2092-99.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2017

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies